Underlying genetic causes of congenital heart disease identified
Researchers have helped shed light on some of the underlying genetic causes of CHD as well as the long-term outlook for patients who carry these mutations...
List view / Grid view
Researchers have helped shed light on some of the underlying genetic causes of CHD as well as the long-term outlook for patients who carry these mutations...
Bacterial composition of breast tissue could offer a new perspective in the battle against breast cancer...
Researchers have found that polymer and hybrid silica-coated microcapsules are efficient in genome-editing...
Brazilian scientists show that parasite's penetration of host cells increases expression of certain microRNAs capable of inhibiting the action of the immune system...
The new imaging agent offers a non-invasive method of detecting infection and monitoring antibiotic therapy...
A new technique for modelling leukaemia may aid drug discovery...
Imaging agents developed to better monitor the growth of tumours and generate new therapies...
A new generation DNA-based Zika vaccine is the first to demonstrate both safety and the ability to elicit an immune response against Zika in humans...
A study that teases apart the biological mechanisms by which HPV cause cancer, has found a strategy that may provide targeted treatment...
Scientists have developed a promising new strategy for the discovery of novel anti-cancer therapies for non-small-cell lung cancers...
Researchers have discovered that impairing a critical partnership between brain cells can lead to neurodegeneration...
Scientists have developed broad-spectrum inhibitors of the influenza virus using artificial peptide molecules...
Collaboration aims to unlock difficult drug targets and accelerate the discovery of new medicines in areas such as infectious diseases and cancer...
Researchers have used CRISPR-Cas9 to inactivate genes in human colorectal cancer cell lines -- one with normal KRAS gene and one with a mutant KRAS...
Drug Target Review welcomes Janusz Kulagowski to its advisory board ...